Mortality News and Research

RSS
Prior COVID highly protective against severe disease ten months post-infection

Prior COVID highly protective against severe disease ten months post-infection

Are SGLT2 inhibitors the next blockbuster drug?

Are SGLT2 inhibitors the next blockbuster drug?

Gut dysbiosis and sepsis susceptibility among pregnant women

Gut dysbiosis and sepsis susceptibility among pregnant women

Cerebral autoregulation displays a daily rhythm in stroke patients

Cerebral autoregulation displays a daily rhythm in stroke patients

One-third of stroke survivors experience depression

One-third of stroke survivors experience depression

Epidemic dynamics of the SARS-CoV-2 Omicron variant in China during the transition from 'zero-COVID' to little-to-no intervention efforts

Epidemic dynamics of the SARS-CoV-2 Omicron variant in China during the transition from 'zero-COVID' to little-to-no intervention efforts

New risk scoring system for acute type A aortic dissection to assess mortality

New risk scoring system for acute type A aortic dissection to assess mortality

Machine learning approach to predict cardiac surgery-associated acute kidney injury

Machine learning approach to predict cardiac surgery-associated acute kidney injury

COVID-19 virus can be detected in tears collected by swabbing, research finds

COVID-19 virus can be detected in tears collected by swabbing, research finds

Omicron has higher risk of in-hospital mortality compared to influenza

Omicron has higher risk of in-hospital mortality compared to influenza

The kids are not OK

The kids are not OK

How well are people with diabetes being supported?

How well are people with diabetes being supported?

How does alcohol affect blood pressure?

How does alcohol affect blood pressure?

Small molecule inhibitor reverses malignant hyper-editing by an inflammation-induced protein isoform

Small molecule inhibitor reverses malignant hyper-editing by an inflammation-induced protein isoform

Nirmatrelvir–ritonavir found to lower COVID-19 severity outcomes

Nirmatrelvir–ritonavir found to lower COVID-19 severity outcomes

Cohort study examines the incidence of SARS-CoV-2 rebound in patients on oral antivirals

Cohort study examines the incidence of SARS-CoV-2 rebound in patients on oral antivirals

Post-COVID-19 CT scans show lung abnormalities persist two years later

Post-COVID-19 CT scans show lung abnormalities persist two years later

Nirmatrelvir-ritonavir therapy effective against Omicron BA.4/BA.5

Nirmatrelvir-ritonavir therapy effective against Omicron BA.4/BA.5

Delayed presentation of MIS-C following COVID-19

Delayed presentation of MIS-C following COVID-19

New insights into the driving factors of COVID-19 dynamics in England

New insights into the driving factors of COVID-19 dynamics in England

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.